OUR STORY

Follow the whole data pipeline from bedside to bench and back to the clinic

BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. Over the years we have fostered strong relationships with local partners such as the Canton of Basel, Novartis, Roche and various incubators to cover the full pipeline of drug development. The congress features senior speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems and academic groups creating endless networking opportunities.

In 2024 BioTechX will return to Basel, the pharma hub of Europe, this time with 3500 global executives, 400 speakers and 100 start-ups all under one roof.

The city of Basel is primarily known as one of the most important locations for the pharmaceutical industry. More than 30,000 people work in the life sciences in the Basel region – from world-leading research groups to biotech entrepreneurs and patent specialists. The Basel region covers the entire value chain from education to sales, forming a cluster that unites universities, university hospitals, global pharmaceutical companies and other research and business institutions.

It is less well known that Basel is the oldest university city in Switzerland and that many health innovations have their origins here. Accordingly, the University of Basel is one of the most important cornerstones of our life science location. Many scientists who were important to the world of medicine have researched and taught at the University of Basel - including Paracelsus and ten Nobel Prize winners. What would Paracelsus have said over 500 years ago if he had heard the topics discussed at the BioTechX congress today? The topics alone show how far we have come in medicine. So much further than even one of the brightest medical minds like Paracelsus could have ever predicted.

Many of the keynotes combine areas that until recently had hardly anything to do with each other. And this shows something that is also becoming increasingly obvious in the field of health care and politics: We have to broaden our horizons and collaborate. We have to work together in an interdisciplinary manner, also across borders of any kind.  

We aim to create conditions that enable the best possible treatment for patients and also for professionals. We promote the exchange between health professionals, researchers and industry.

At events such as BioTechX Europe, we can see exactly how beneficial such role-model collaborations between research and industry can be.

With 16 tracks of high-level content, the agenda covers everything from the use and management of multiomic data to the development of personalised therapies as well as covering the actual generation of the data. We will also have our poster area where attendees can display their scientific research and present this to other participants.

At a time where biotech is taking off, we gather the leaders of biotech, pharma, fast-growing industry start-ups and established solution providers to give us an insight of where the industry is heading next.

Richness and diversity of contributions as well as participants at the conference

Head of Group Digital Governance - SANOFI